Newsletter | July 9, 2021

07.09.21 -- Keys To A Successful Rapid Commercial Launch

Keys To A Successful Rapid Commercial Launch

For new biologics and drug development, the quicker a company can get its product to patients, the better. Combining a rapid launch following regulatory approval with effective messaging and post-launch services can provide a competitive advantage.

Elemental Impurities Risk Assessment For Finished Drug Products

This webinar reviews the impact of the most recent regulatory changes related to elemental impurities testing, guidance on the best routes to compliance, and an overview of the elemental impurities risk assessment process.

Analytical Quality By Design Using Design Of Experiments

Design of experiment (DoE) is the centerpiece of analytical quality by design. Explore our DoE assay development pipeline approach, which delivers optimized, robust, and rugged analytical methods ready for method qualification.